Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
24.61
+0.83 (3.49%)
Jan 21, 2025, 4:00 PM EST - Market closed

Celldex Therapeutics Market Cap

Celldex Therapeutics has a market cap or net worth of $1.63 billion as of January 21, 2025. Its market cap has decreased by -12.23% in one year.

Market Cap
1.63B
Enterprise Value
879.82M
1-Year Change
-12.23%
Ranking
Category
Stock Price
$24.61

Market Cap Chart

Since July 23, 2003, Celldex Therapeutics's market cap has increased from $148.10M to $1.63B, an increase of 1,002.45%. That is a compound annual growth rate of 11.81%.

History

DateMarket Cap% Change
Jan 17, 20251.58B-5.89%
Dec 31, 20241.68B-10.56%
Dec 29, 20231.87B-10.70%
Dec 30, 20222.10B16.42%
Dec 31, 20211.80B160.11%
Dec 31, 2020693.20M1,825.56%
Dec 31, 201936.00M5.57%
Dec 31, 201834.10M-91.17%
Dec 29, 2017386.20M7.76%
Dec 30, 2016358.40M-76.83%
Dec 31, 20151.55B-5.39%
Dec 31, 20141.64B-16.73%
Dec 31, 20131.96B372.13%
Dec 31, 2012415.90M262.28%
Dec 30, 2011114.80M-13.10%
Dec 31, 2010132.10M-10.50%
Dec 31, 2009147.60M17.99%
Dec 31, 2008125.10M237.20%
Dec 31, 200737.10M-62.68%
Dec 29, 200699.40M-28.69%
Dec 30, 2005139.40M-6.44%
Dec 31, 2004149.00M-15.96%
Dec 31, 2003177.30M19.72%
View and export this data all the way back to 2003. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 653.46B
UnitedHealth Group 469.12B
Johnson & Johnson 353.99B
Novo Nordisk 352.70B
AbbVie 303.17B
Merck & Co. 247.70B
Thermo Fisher Scientific 214.07B
Intuitive Surgical 211.09B
Market Cap Rankings